Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
QuintilesIMS
Chubb
Medtronic
Covington
Express Scripts
Healthtrust
Teva
Merck

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019625

« Back to Dashboard

NDA 019625 describes ELOCON, which is a drug marketed by Merck Sharp Dohme and is included in three NDAs. It is available from two suppliers. Additional details are available on the ELOCON profile page.

The generic ingredient in ELOCON is mometasone furoate. There are twenty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 019625
Tradename:ELOCON
Applicant:Merck Sharp Dohme
Ingredient:mometasone furoate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 019625
Medical Subject Heading (MeSH) Categories for 019625
Suppliers and Packaging for NDA: 019625
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ELOCON mometasone furoate CREAM;TOPICAL 019625 NDA Merck Sharp & Dohme Corp. 0085-3149 N 0085-3149-01
ELOCON mometasone furoate CREAM;TOPICAL 019625 NDA Merck Sharp & Dohme Corp. 0085-3149 N 0085-3149-02

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength0.1%
Approval Date:May 6, 1987TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.1%
Approval Date:Apr 19, 2013TE:ABRLD:Yes

Expired US Patents for NDA 019625

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme ELOCON mometasone furoate CREAM;TOPICAL 019625-001 May 6, 1987 ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme ELOCON mometasone furoate CREAM;TOPICAL 019625-001 May 6, 1987 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Daiichi Sankyo
Citi
Baxter
QuintilesIMS
Colorcon
Cipla
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.